Lesheng S. Teng
2699 Qianjin Street
Changchun, 130012, China
Changchun, 130012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Cell-Penetrating Peptide Conjugated Polyzwitterion-Drug Enhances Tumor Retention.
Journal: Nano letters
Published: June 22, 2026
Neutrophil-Mediated Drug Delivery Nanoplatform Constructed from Celastrol Loaded Liposome for Targeted Therapy of Rheumatoid Arthritis.
Journal: Nano letters
Published: February 16, 2026
Immunological conversion of triple-negative breast cancer by engineered extracellular vesicle-mediated pyroptosis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 08, 2025
A lymph node-targeted cell-nanoadjuvant conjugate enhances dendritic cell-T cell crosstalk for cancer immunotherapy.
Journal: Acta pharmaceutica Sinica. B
Published: August 10, 2025
A Generative Artificial Intelligence Copilot for Biomedical Nanoengineering.
Journal: ACS nano
Published: May 14, 2025
Correction: Folate receptor-targeting mesoporous silica-coated gold nanorod nanoparticles for the synergistic photothermal therapy and chemotherapy of rheumatoid arthritis.
Journal: RSC advances
Published: April 28, 2025
LPAR4-targeted dual-loaded liposome for synergistic lung cancer therapy.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 15, 2025
Precise nanoscale fabrication technologies, the "last mile" of medicinal development.
Journal: Acta pharmaceutica Sinica. B
Published: September 20, 2024
Nano-oncology revisited: Insights on precise therapeutic advances and challenges in tumor.
Journal: Fundamental research
Published: September 12, 2024
New avenues for cancer immunotherapy: Cell-mediated drug delivery systems.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 01, 2024
Synergistic Effect of Doxorubicin and Blue Light Irradiation on the Antitumor Treatment of HepG2 Cells in Liver Cancer.
Journal: Molecules (Basel, Switzerland)
Published: May 23, 2024
Last Updated: 09/26/2026